GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabion SA (WAR:MAB) » Definitions » Pretax Margin %

Mabion (WAR:MAB) Pretax Margin % : -3,157.36% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Mabion Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Mabion's Pre-Tax Income for the three months ended in Sep. 2024 was zł-16.3 Mil. Mabion's Revenue for the three months ended in Sep. 2024 was zł0.5 Mil. Therefore, Mabion's pretax margin for the quarter that ended in Sep. 2024 was -3,157.36%.

The historical rank and industry rank for Mabion's Pretax Margin % or its related term are showing as below:

WAR:MAB' s Pretax Margin % Range Over the Past 10 Years
Min: -1556.57   Med: -18.03   Max: 32.89
Current: 17.03


WAR:MAB's Pretax Margin % is ranked better than
87.04% of 995 companies
in the Biotechnology industry
Industry Median: -125.57 vs WAR:MAB: 17.03

Mabion Pretax Margin % Historical Data

The historical data trend for Mabion's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabion Pretax Margin % Chart

Mabion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -18.03 13.44 32.89

Mabion Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.70 15.74 51.63 34.56 -3,157.36

Competitive Comparison of Mabion's Pretax Margin %

For the Biotechnology subindustry, Mabion's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mabion's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mabion's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Mabion's Pretax Margin % falls into.


;
;

Mabion Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Mabion's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=49.894/151.678
=32.89 %

Mabion's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-16.292/0.516
=-3,157.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mabion  (WAR:MAB) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Mabion Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Mabion's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mabion Business Description

Traded in Other Exchanges
N/A
Address
ul. Gen. Mariana Langiewicza 60, Konstantynow Lodzki, POL, 95-050
Mabion SA is a Polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. The drugs developed by the company are targeted treatments, characterized by the drug's ability to recognize the factor causing cancer and interact with this factor only. The company is working on the development of its main priority drug, referred to as the MabionCD20 drug. The therapeutic uses of MabionCD20 are for Non-Hodgkin's lymphoma, Leukemia, and Rheumatoid Arthritis.

Mabion Headlines